Transforming growth factor-beta in the development of rat diabetic nephropathy?

Nephron

Volumn 74, Issue 1, 1996, Pages 189-196

  Bertoluci, Marcello Casaccia ^a   Schmid, Helena ^a   Lachat, Joao Jose ^b   Coimbra, Terezila Machado ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Diabetic nephropathy; Extracellular matrix; Progressive renal disease; Transforming growth factor

Indexed keywords

ALBUMIN; COLLAGEN TYPE 1; GROWTH FACTOR; MESSENGER RNA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; GLOMERULUS; GLOMERULUS FILTRATION RATE; IMMUNOHISTOCHEMISTRY; KIDNEY CORTEX; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; STREPTOZOCIN DIABETES; URINARY EXCRETION;

ANIMALS; BLOTTING, NORTHERN; DIABETIC NEPHROPATHIES; FEMALE; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; INSULIN; KIDNEY CORTEX; KIDNEY FUNCTION TESTS; RATS; RATS, WISTAR; RNA, MESSENGER; SCLEROSIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029769666     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000189300     Document Type: Article

References (35)

1. Ostcrby R. Gundcrsen HJG: Glomerular size and structure in diabetes mellitus. 1. Early abnormalities. Diabetologia 1975:11:225-229.
2. Kimmelstiel P. Wilson C: Intercapillarv lesions in glomeruli of kidney. Am J Pathol 1936,12: 83-97.
3. Ostcrbv R. Parving HH, Nybcrg G, Hommcl E, Jorgensen HE. Lokkcgaard H. Svalandcr C: A strong correlation between glomerular filtration rale and filtration surface in diabetic nephropathy. Diabetologia 1988:31:265-270.
4. Zatz R. Dunn BR. Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986;77:1925-1930.
5. Hostcttcr TH: Diabetic Nephropathy: in Brenner BM, Rector FC (eds): The Kidney, ed 4. Philadelphia, Saunders, 1991, pp 1695-1727.
6. Krolcwski AS, Cancssa M. Warrant JH, Laffel LMB, Christlieb R. Knowlcr WC, Rand LI: Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988:318:140-150.
7. Klahr S, Schreiner G. Ichikawa I: The progression of renal disease. N EngJ J Med 1988:318: 1657-1666.
8. Nerlich A. Schleicher E: Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions. Am J Pathol 1991:139:889-899.
9. Sporn MB. Roberts AB. Wakefield LM: Some recent advances in the chemistry and biology of transforming growth factor-beta, J Cell Biol 1987;105:1039-1045.
10. MacKav K. Striker U. Stauffer JW, Doi T. Agodoa LY, Striker GH: Transforming growth factor-p. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest 1989:83:1160-1167.
11. Border WA, Okuda S, Languino LR. Ruoslahti E: Transforming growth factor-P regulates production of proteoglycans by mesangial cells. Kidney Int 1990;37:689-695.
12. Roberts AB, Sporn MB. Assoian RK. Smith JM, Roche NS, Wakefield LM. Heine UI, Liot-ta LA, Fallanga V. Kehrl JH, Fauci AS: Transforming growth factor type P: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl AcadSci USA 1986;83:4167-4171.
13. Creely JJ. DiMari SJ, Howe AM, Haralson MA: Effects of transforming growth factor-p on collagen synthesis by normal rat kidney epithelial cells. Am J Pathol 1992;140:45-55.
14. ignotz RA. Massagué J: Transforming growth factor p stimulates the expression of fibronec-tin and collagen and their incorporation into extracellular matrix. J Biol Chem 1986:261: 4337-4345.
15. Edwards DR. Murphy G. Reynolds JJ. Whit-ham SE. Dochertv AJP, Angel P. Heath JK: Transforming growth factor-beta modulates the expression of collagenase and metallopro-tease inhibitor. EMBO J 1987;7:1899-1904.
16. Nakamura T. Fukui M. Ebihara I. Osada S. Nagaoka 1. Tomino Y. Koide H: mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 1993:42:450-456.
17. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E. Border WA: Expression of transforming growth factor-p is elevated in human and experimental diabetic nephropathy. Proc Natl AcadSci USA 1993:90:1814-1818.
18. Larclt CB: Electroimmunoassay. Scand J Clin Lab Invest 1972; 124(suppl)21-23.
19. Coimbra TM, Furtado MR, Lachat JJ. Carvalho IF: Effects of administration of cationic and native homologous albumin on the kidnev. Nephron 1983;33:208-215.
20. Fuehr Y. Kaczmarczyk Y, Kruttgcn GD: Eine einfache colorimetrische Methode zur Inulin-Bestimmung für Nicren-Clcarance-Untersu-chungen bei Stoffwcchsclgesunden und Diabetikern. Klin Wochenschr 1955:33:729-739.
21. Shankland SJ, Scholey J W: Expression of transforming growth factor-pl during diabetic renal hypertrophy. Kidney Int 46:1994:430-442.
22. Chomczynski P. Sacchi N: Single step method ofRNA isolation by acid guanidinium thiocya-nate-phenol-chlorophorm extraction. Anal Bio-chem 1987;162:156-159.
23. Dcrynck R. Jarrett JA, Chen EY. Eaton DH. Bell JR, Assoian RK. Roberts AB. Sporn MB, Goeddel DV: Human transforming growth factor p complementary DNA sequence and expression in normal and transformed cells. Nature 1985;316:701-705.
24. Feinberg AP, Vogelstein B: A technique for radiolabcling DNA restriction endonuclease fragments to high specific activity. Anal Bio-chcm 1983;132:6-13.
25. Okuda S, Languino R. Ruoslathi E. Border WA: Elevated expression of transforming growth factor-p and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 1990;86:453-462.
26. Coimbra TM, Wiggins R, Noh JW. Merritt S, Phan SH: Transforming growth factor-p production in anti-glomerular basement membrane disease in the rabbit. Am J Pathol 1991; 138:223-234.
27. Isaka Y. Fujiwara Y. Ueda N, Kaneda Y, Ka-rnada T. Imai E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest 1993:92: 2597-2601.
28. Wolf G. Sharma K, Chen Y. Erickscn M. Ziyadch FN: High glucose induced proliferation in mcsangial cells is reversed by autocrine TGF-p. Kidney Int 1992;42:647-656.
29. Hancda M. Kikkawa R. Horide N. Togawa M, Koya D. Kajiwara N. Ooshima A, Shigeta Y: Glucose enhances type IV collagen production in cultured rat glomerular mcsangial cells. Dia-betoiogia 1991;34:198-200.
30. Ayo SH, Radnik RA. Garoni JA. Glass WF H. Kreisberg JI: High glucose causes an increase in extracellular matrix proteins in cultured mcsangial cells. Am J Pathol 1990; 136:1339-1348.
31. Kagami S. Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-P expression in rat glomerular mcsangial cells. J Clin Invest 1994;93: 2431-2437.
32. Anderson S. Jung FF. Ingelfinger JR: Renal renin-angiotensin system in diabetes: Functional, immunohistochcmical and molecular biological correlations. Am J Physiol 1993:265. F477-F486.
33. Riser BL, Cortes P. Zhao X. Bernstein J, Dum-Icr F. Narins RG: Intraglomerular pressure and mcsangial stretching stimulate extracellular matrix formation in rat. J Clin Invest 1992:90: 1932-1943.
34. Kempc HP. Engelmann K, Grclz N. Hasslaeher C: Models of diabetes for studying diabetic nephropathy; in Grctz N. Strauch M (eds): Experimental and Genetic Rat Models of Chronic Renal Failure. Basel, Karger. 1993. pp 148-155.
35. Okuda S. Nakamura T. Yamamoto T, Ruos-lahti E, Border WA: Dietary protein restriction rapidly reduces transforming growth factor III expression in experimental glomerulonephritis. Proc Natl Acad Sei USA 1991:88:9765-9769.